MEDICLIN Reports Solid H1 2026 with Revenue Up 5%

MEDICLIN Aktiengesellschaft, a leading German healthcare provider, has announced robust financial results for the first half of 2026, demonstrating steady growth and operational stability. The company treated 54,708 patients, up from 53,183 in the previous year, while consolidated group revenues rose 5.0% to EUR 386.4 million (previous year: EUR 368.1 million). Group EBIT improved significantly to EUR 26.6 million from EUR 22.4 million, reflecting efficient cost management and targeted investments. CFO Tino Fritz attributed the performance to consistent momentum from the first quarter, highlighting stability in core business areas and a commitment to long-term growth.

Segment-wise, the Post-Acute segment generated revenues of EUR 263.0 million, a 4.6% increase, with EBIT rising to EUR 25.6 million. The Acute Care segment saw revenues climb to EUR 111.2 million, though EBIT remained flat at EUR -1.1 million due to higher material costs. The Care segment posted a slight revenue increase to EUR 12.3 million, turning EBIT positive at EUR 0.2 million. The Service segment reported other income of EUR 69.2 million and EBIT of EUR 1.9 million, up from EUR 0.5 million. The management board reaffirmed its outlook for the full year, expecting consolidated group revenue growth of 3.5% to 6.5% and group EBIT between EUR 57.0 million and EUR 72.0 million. The interim report is available at www.mediclin.de.

MEDICLIN operates 31 clinics, six care homes, and ten medical care centres across Germany, employing around 9,900 staff. As part of the ASKLEPIOS Group, the company offers integrated care from initial consultation through surgery and rehabilitation to outpatient aftercare. The positive half-year results underscore MEDICLIN’s resilience in a challenging healthcare environment and its ability to balance cost pressures with patient care quality. For more details, view the original release on NEWMEDIAWIRE.